Data:
{
"symbol": "SRPT",
"price": 19.825,
"marketCap": 2093044200,
"beta": 0.205,
"lastDividend": 0,
"range": "14.68-25.32",
"change": 1.805,
"changePercentage": 10.01665,
"volume": 1361828,
"averageVolume": 3166260,
"companyName": "Sarepta Therapeutics, Inc.",
"currency": "USD",
"cik": "0000873303",
"isin": "US8036071004",
"cusip": "803607100",
"exchangeFullName": "NASDAQ Global Select",
"exchange": "NASDAQ",
"industry": "Biotechnology",
"website": "https://www.sarepta.com",
"description": "Sarepta Therapeutics, Inc. is a commercial-stage biopharmaceutical company dedicated to the discovery and advancement of genetic treatment modalities, including RNA-targeted therapeutics and gene therapies, specifically for rare diseases. The company currently offers two approved treatments: EXONDYS 51, prescribed for Duchenne muscular dystrophy (DMD) patients with confirmed dystrophin gene mutations amenable to exon 51 skipping, and VYONDYS 53, for DMD patients with exon 53 skipping mutations. Sarepta's development pipeline includes AMONDYS 45, an exon-skipping product candidate utilizing phosphorodiamidate morpholino oligomer chemistry for exon 45; SRP-5051, a peptide-conjugated PMO designed to target exon 51 of dystrophin pre-mRNA; and gene therapy programs such as SRP-9001 for DMD and SRP-9003 for limb-girdle muscular dystrophies. The company maintains collaborative agreements with organizations like F. Hoffman-La Roche Ltd, Nationwide Children's Hospital, Lysogene, Duke University, Genethon, and StrideBio. Founded in 1980, Sarepta Therapeutics is headquartered in Cambridge, Massachusetts.",
"ceo": "Michael E. Severino",
"sector": "Healthcare",
"country": "US",
"fullTimeEmployees": "835",
"phone": "617 274 4000",
"address": "215 First Street",
"city": "Cambridge",
"state": "MA",
"zip": "02142",
"image": "https://images.financialmodelingprep.com/symbol/SRPT.png",
"ipoDate": "1997-06-04",
"defaultImage": false,
"isEtf": false,
"isActivelyTrading": true,
"isAdr": false,
"isFund": false
}
Data:
{
"symbol": "SRPT",
"name": "Sarepta Therapeutics, Inc.",
"price": 19.845,
"changePercentage": 10.12763,
"change": 1.825,
"volume": 1361534,
"dayLow": 18.74,
"dayHigh": 20.1495,
"yearHigh": 25.32,
"yearLow": 14.68,
"marketCap": 2095155648,
"priceAvg50": 17.066,
"priceAvg200": 19.08765,
"exchange": "NASDAQ",
"open": 18.74,
"previousClose": 18.02,
"timestamp": 1787150289,
"chart_vwap_daily": [
{
"t": "2026-07-09",
"v": 20.3926,
"c": 20.52
},
{
"t": "2026-07-10",
"v": 19.062,
"c": 18.95
},
{
"t": "2026-07-13",
"v": 18.8471,
"c": 18.82
},
{
"t": "2026-07-14",
"v": 18.0957,
"c": 17.96
},
{
"t": "2026-07-15",
"v": 17.448,
"c": 17.61
},
{
"t": "2026-07-16",
"v": 17.4177,
"c": 17.23
},
{
"t": "2026-07-17",
"v": 17.2225,
"c": 17.22
},
{
"t": "2026-07-20",
"v": 17.0424,
"c": 16.83
},
{
"t": "2026-07-21",
"v": 16.366,
"c": 16.21
},
{
"t": "2026-07-22",
"v": 16.0084,
"c": 15.82
},
{
"t": "2026-07-23",
"v": 15.8501,
"c": 15.88
},
{
"t": "2026-07-24",
"v": 15.7318,
"c": 15.68
},
{
"t": "2026-07-27",
"v": 16.1927,
"c": 15.89
},
{
"t": "2026-07-28",
"v": 15.3326,
"c": 15.43
},
{
"t": "2026-07-29",
"v": 15.5373,
"c": 15.535
},
{
"t": "2026-07-30",
"v": 15.3672,
"c": 15.56
},
{
"t": "2026-07-31",
"v": 15.0205,
"c": 14.86
},
{
"t": "2026-08-03",
"v": 15.5335,
"c": 15.88
},
{
"t": "2026-08-04",
"v": 16.1779,
"c": 16.39
},
{
"t": "2026-08-05",
"v": 16.1457,
"c": 15.93
},
{
"t": "2026-08-06",
"v": 16.7778,
"c": 16.78
},
{
"t": "2026-08-07",
"v": 16.7643,
"c": 16.78
},
{
"t": "2026-08-10",
"v": 16.9442,
"c": 17.18
},
{
"t": "2026-08-11",
"v": 17.9562,
"c": 18.22
},
{
"t": "2026-08-12",
"v": 18.2809,
"c": 18.38
},
{
"t": "2026-08-13",
"v": 18.4262,
"c": 18.42
},
{
"t": "2026-08-14",
"v": 17.9636,
"c": 18.1
},
{
"t": "2026-08-17",
"v": 18.1201,
"c": 18.18
},
{
"t": "2026-08-18",
"v": 18.017,
"c": 18.02
},
{
"t": "2026-08-19",
"v": 19.5574,
"c": 19.835
}
],
"vwap_summary": {
"days": 30,
"days_above": 16,
"days_below": 14,
"pct_days_above": 53,
"position": "above",
"gap_pct": 1.42,
"streak_days": 4
}
}
Data:
{
"volume": 1361534,
"avgVolume": 3166260,
"short_ratio": [
{
"symbol": "SRPT",
"file_date": "2026-08-18",
"date": "20260818",
"short_volume": 254060,
"short_exempt_volume": 600,
"total_volume": 457292,
"short_volume_ratio": 0.5556,
"signal": "Bearish"
}
],
"volume_profile": {
"poc": 15.91,
"vah": 16.95,
"val": 14.87,
"profile": [
{
"price": 14.91,
"volume": 666764
},
{
"price": 15.0,
"volume": 1178084
},
{
"price": 15.08,
"volume": 1445566
},
{
"price": 15.16,
"volume": 1031981
},
{
"price": 15.25,
"volume": 2153070
},
{
"price": 15.33,
"volume": 1847486
},
{
"price": 15.41,
"volume": 1835989
},
{
"price": 15.5,
"volume": 663211
},
{
"price": 15.58,
"volume": 1441093
},
{
"price": 15.66,
"volume": 1438058
},
{
"price": 15.74,
"volume": 871287
},
{
"price": 15.83,
"volume": 1983952
},
{
"price": 15.91,
"volume": 2267674
},
{
"price": 15.99,
"volume": 357917
},
{
"price": 16.08,
"volume": 718162
},
{
"price": 16.16,
"volume": 479363
},
{
"price": 16.24,
"volume": 1064513
},
{
"price": 16.32,
"volume": 1437083
},
{
"price": 16.41,
"volume": 1223574
},
{
"price": 16.49,
"volume": 868798
},
{
"price": 16.57,
"volume": 935035
},
{
"price": 16.66,
"volume": 1275586
},
{
"price": 16.74,
"volume": 1713913
},
{
"price": 16.82,
"volume": 1354597
},
{
"price": 16.9,
"volume": 1237435
},
{
"price": 16.99,
"volume": 603666
},
{
"price": 17.07,
"volume": 497522
},
{
"price": 17.15,
"volume": 389722
},
{
"price": 17.24,
"volume": 0
},
{
"price": 17.32,
"volume": 0
},
{
"price": 17.4,
"volume": 34972
},
{
"price": 17.49,
"volume": 0
},
{
"price": 17.57,
"volume": 0
},
{
"price": 17.65,
"volume": 66066
},
{
"price": 17.73,
"volume": 395845
},
{
"price": 17.82,
"volume": 793546
},
{
"price": 17.9,
"volume": 1647599
},
{
"price": 17.98,
"volume": 1192920
},
{
"price": 18.07,
"volume": 710482
},
{
"price": 18.15,
"volume": 1160570
},
{
"price": 18.23,
"volume": 475979
},
{
"price": 18.31,
"volume": 935252
},
{
"price": 18.4,
"volume": 1191571
},
{
"price": 18.48,
"volume": 437215
},
{
"price": 18.56,
"volume": 71361
},
{
"price": 18.65,
"volume": 114043
},
{
"price": 18.73,
"volume": 9788
},
{
"price": 18.81,
"volume": 0
},
{
"price": 18.89,
"volume": 61640
},
{
"price": 18.98,
"volume": 0
},
{
"price": 19.06,
"volume": 0
},
{
"price": 19.14,
"volume": 57080
},
{
"price": 19.23,
"volume": 59086
},
{
"price": 19.31,
"volume": 45154
},
{
"price": 19.39,
"volume": 102293
},
{
"price": 19.48,
"volume": 374544
},
{
"price": 19.56,
"volume": 71433
},
{
"price": 19.64,
"volume": 53527
},
{
"price": 19.72,
"volume": 0
},
{
"price": 19.81,
"volume": 500393
}
],
"sessions": 20
}
}
Data:
{
"symbol": "SRPT",
"marketCap": 2090404800,
"enterpriseValueTTM": 2567217320,
"evToSalesTTM": 1.299219284987824,
"evToOperatingCashFlowTTM": -27.980428688301064,
"evToFreeCashFlowTTM": -19.51140438284893,
"evToEBITDATTM": -175.8849286889742,
"netDebtToEBITDATTM": -32.54943773998903,
"currentRatioTTM": 4.421930054801276,
"incomeQualityTTM": -0.47198224821606927,
"grahamNumberTTM": null,
"grahamNetNetTTM": -0.5513795752672364,
"taxBurdenTTM": 1.0443400549954172,
"interestBurdenTTM": 2.2081295328048576,
"workingCapitalTTM": 1720916000,
"investedCapitalTTM": 2198363000,
"returnOnAssetsTTM": -0.04288050350759225,
"operatingReturnOnAssetsTTM": -0.04499386410187067,
"returnOnTangibleAssetsTTM": -0.04329613670844228,
"returnOnEquityTTM": -0.09955144510690722,
"returnOnInvestedCapitalTTM": -0.05333921158890142,
"returnOnCapitalEmployedTTM": -0.05333921158890142,
"earningsYieldTTM": -0.0654959455027746,
"freeCashFlowYieldTTM": -0.0628906898797783,
"capexToOperatingCashFlowTTM": -0.4340550859012817,
"capexToDepreciationTTM": 0.7195660036166365,
"capexToRevenueTTM": 0.020154542470815624,
"salesGeneralAndAdministrativeToRevenueTTM": 0.22120815825408338,
"researchAndDevelopementToRevenueTTM": 0.3998512923786331,
"stockBasedCompensationToRevenueTTM": 0.06493954447654512,
"intangiblesToTotalAssetsTTM": 0.009599775694744132,
"averageReceivablesTTM": 515260000,
"averagePayablesTTM": 60679000,
"averageInventoryTTM": 952692500,
"daysOfSalesOutstandingTTM": 89.22048032156503,
"daysOfPayablesOutstandingTTM": 22.74229739804212,
"daysOfInventoryOutstandingTTM": 403.38247803184925,
"operatingCycleTTM": 492.6029583534143,
"cashConversionCycleTTM": 469.86066095537217,
"freeCashFlowToEquityTTM": -281991000,
"freeCashFlowToFirmTTM": -61978713.45096242,
"tangibleAssetValueTTM": 1497189000,
"netCurrentAssetValueTTM": 563110000,
"grossProfitMarginTTM": 0.5855686749624179,
"ebitMarginTTM": -0.03003022776172744,
"ebitdaMarginTTM": -0.0073867573229386575,
"operatingProfitMarginTTM": -0.07255473210342271,
"pretaxProfitMarginTTM": -0.06631063279752668,
"continuousOperationsProfitMarginTTM": -0.06925084990254991,
"netProfitMarginTTM": -0.06925084990254991,
"bottomLineProfitMarginTTM": -0.06925084990254991,
"receivablesTurnoverTTM": 4.090988959984086,
"payablesTurnoverTTM": 16.04938998077753,
"inventoryTurnoverTTM": 0.9048484251990273,
"fixedAssetTurnoverTTM": 4.418478285195082,
"assetTurnoverTTM": 0.6192054475567287,
"quickRatioTTM": 2.6238417364607445,
"solvencyRatioTTM": -0.055409299855363414,
"cashRatioTTM": 1.1356908221782116,
"priceToEarningsRatioTTM": -13.763888888888886,
"priceToEarningsGrowthRatioTTM": 0.0157883672754443,
"forwardPriceToEarningsGrowthRatioTTM": 0.17657272443282138,
"priceToEarningsDilutedRatioTTM": -6.834482758620689,
"priceToEarningsDilutedGrowthRatioTTM": 0.021364217189886275,
"priceToBookRatioTTM": 1.3677478436285426,
"priceToSalesRatioTTM": 1.0598539666846305,
"priceToFreeCashFlowRatioTTM": -15.916665931374414,
"priceToOperatingCashFlowRatioTTM": -22.794026943005186,
"debtToAssetsRatioTTM": 0.3280053517126484,
"debtToEquityRatioTTM": 0.6845466481825477,
"debtToCapitalRatioTTM": 0.4063684724439676,
"longTermDebtToCapitalRatioTTM": 0.35683064181044116,
"financialLeverageRatioTTM": 2.0869984120937453,
"workingCapitalTurnoverRatioTTM": 1.118092845565841,
"operatingCashFlowRatioTTM": -0.18228980250860993,
"operatingCashFlowSalesRatioTTM": -0.04643314437605605,
"freeCashFlowOperatingCashFlowRatioTTM": 1.4340550859012817,
"debtServiceCoverageRatioTTM": -0.3494198899761786,
"interestCoverageRatioTTM": -2.454936504944217,
"shortTermOperatingCashFlowCoverageRatioTTM": 0,
"operatingCashFlowCoverageRatioTTM": -0.08765605742320354,
"capitalExpenditureCoverageRatioTTM": -2.30385504624045,
"dividendPaidAndCapexCoverageRatioTTM": -2.30385504624045,
"dividendPayoutRatioTTM": 0,
"dividendYieldTTM": 0,
"revenuePerShareTTM": 18.72640874126206,
"netIncomePerShareTTM": -1.2968197209549372,
"interestDebtPerShareTTM": 10.47320048183172,
"cashPerShareTTM": 7.478720679875938,
"bookValuePerShareTTM": 14.490975140139048,
"tangibleBookValuePerShareTTM": 14.200652559493887,
"shareholdersEquityPerShareTTM": 14.490975140139048,
"operatingCashFlowPerShareTTM": -0.8695260407280591,
"capexPerShareTTM": 0.37742220030161905,
"freeCashFlowPerShareTTM": -1.2469482410296782,
"netIncomePerEBTTTM": 1.0443400549954172,
"ebtPerEbitTTM": 0.9139394616329722,
"priceToFairValueTTM": 1.3677478436285426,
"debtToMarketCapTTM": 0.4050735432256987,
"effectiveTaxRateTTM": -0.04434005499541705,
"enterpriseValueMultipleTTM": -176.0297120131651,
"dividendPerShareTTM": 0,
"revenue_history": [
{
"date": "2025",
"revenue": 2198237000
}
],
"dcf": {
"symbol": "SRPT",
"date": "2026-08-18",
"dcf": -1291.6681480940256,
"Stock Price": 17.9312
},
"statements": {
"income": [
{
"date": "2025-12-31",
"symbol": "SRPT",
"reportedCurrency": "USD",
"cik": "0000873303",
"filingDate": "2026-03-02",
"acceptedDate": "2026-03-02 07:02:15",
"fiscalYear": "2025",
"period": "FY",
"revenue": 2198237000,
"costOfRevenue": 881504000,
"grossProfit": 1316733000,
"researchAndDevelopmentExpenses": 1522066000,
"generalAndAdministrativeExpenses": 478936000,
"sellingAndMarketingExpenses": 0,
"sellingGeneralAndAdministrativeExpenses": 478936000,
"otherExpenses": -26497000,
"operatingExpenses": 1974505000,
"costAndExpenses": 2856009000,
"netInterestIncome": 9838000,
"interestIncome": 19569000,
"interestExpense": 9731000,
"depreciationAndAmortization": 44521000,
"ebitda": -647973000,
"ebit": -692494000,
"nonOperatingIncomeExcludingInterest": 34722000,
"operatingIncome": -657772000,
"totalOtherIncomeExpensesNet": -44453000,
"incomeBeforeTax": -702225000,
"incomeTaxExpense": 11185000,
"netIncomeFromContinuingOperations": -713410000,
"netIncomeFromDiscontinuedOperations": 0,
"otherAdjustmentsToNetIncome": 0,
"netIncome": -713410000,
"netIncomeDeductions": 0,
"bottomLineNetIncome": -713410000,
"eps": -7.13,
"epsDiluted": -7.13,
"weightedAverageShsOut": 104793000,
"weightedAverageShsOutDil": 104793000
}
],
"balance_sheet": [
{
"date": "2025-12-31",
"symbol": "SRPT",
"reportedCurrency": "USD",
"cik": "0000873303",
"filingDate": "2026-03-02",
"acceptedDate": "2026-03-02 07:02:15",
"fiscalYear": "2025",
"period": "FY",
"cashAndCashEquivalents": 801282000,
"shortTermInvestments": 138368000,
"cashAndShortTermInvestments": 939650000,
"netReceivables": 519610000,
"accountsReceivables": 398233000,
"otherReceivables": 121377000,
"inventory": 914744000,
"prepaids": 154733000,
"otherCurrentAssets": 9201000,
"totalCurrentAssets": 2537938000,
"propertyPlantEquipmentNet": 470620000,
"goodwill": 0,
"intangibleAssets": 28949000,
"goodwillAndIntangibleAssets": 28949000,
"longTermInvestments": 1048000,
"taxAssets": 0,
"otherNonCurrentAssets": 311148000,
"totalNonCurrentAssets": 811765000,
"otherAssets": 0,
"totalAssets": 3349703000,
"totalPayables": 285596000,
"accountPayables": 280841000,
"otherPayables": 4755000,
"accruedExpenses": 178779000,
"shortTermDebt": 0,
"capitalLeaseObligationsCurrent": 11393000,
"taxPayables": 0,
"deferredRevenue": 443397000,
"otherCurrentLiabilities": 176125000,
"totalCurrentLiabilities": 1095290000,
"longTermDebt": 828974000,
"capitalLeaseObligationsNonCurrent": 199378000,
"deferredRevenueNonCurrent": 83910000,
"deferredTaxLiabilitiesNonCurrent": 0,
"otherNonCurrentLiabilities": 1529000,
"totalNonCurrentLiabilities": 1113791000,
"otherLiabilities": 0,
"capitalLeaseObligations": 210771000,
"totalLiabilities": 2209081000,
"treasuryStock": -25263000,
"preferredStock": 0,
"commonStock": 11000,
"retainedEarnings": -4876984000,
"additionalPaidInCapital": 6042586000,
"accumulatedOtherComprehensiveIncomeLoss": 272000,
"otherTotalStockholdersEquity": 0,
"totalStockholdersEquity": 1140622000,
"totalEquity": 1140622000,
"minorityInterest": 0,
"totalLiabilitiesAndTotalEquity": 3349703000,
"totalInvestments": 139416000,
"totalDebt": 1039745000,
"netDebt": 238463000
}
],
"cash_flow": [
{
"date": "2025-12-31",
"symbol": "SRPT",
"reportedCurrency": "USD",
"cik": "0000873303",
"filingDate": "2026-03-02",
"acceptedDate": "2026-03-02 07:02:15",
"fiscalYear": "2025",
"period": "FY",
"netIncome": -713410000,
"depreciationAndAmortization": 44521000,
"deferredIncomeTax": 0,
"stockBasedCompensation": 123396000,
"changeInWorkingCapital": 78038000,
"accountsReceivables": 203755000,
"inventory": -301093000,
"accountsPayables": 104269000,
"otherWorkingCapital": 71107000,
"otherNonCashItems": 261976000,
"netCashProvidedByOperatingActivities": -205479000,
"investmentsInPropertyPlantAndEquipment": -101972000,
"acquisitionsNet": 0,
"purchasesOfInvestments": -44658000,
"salesMaturitiesOfInvestments": 469966000,
"otherInvestingActivities": -253695000,
"netCashProvidedByInvestingActivities": 69641000,
"netDebtIssuance": -162588000,
"longTermNetDebtIssuance": -162588000,
"shortTermNetDebtIssuance": 0,
"netStockIssuance": 11304000,
"netCommonStockIssuance": 11304000,
"commonStockIssuance": 36317000,
"commonStockRepurchased": -25013000,
"netPreferredStockIssuance": 0,
"netDividendsPaid": 0,
"commonDividendsPaid": 0,
"preferredDividendsPaid": 0,
"otherFinancingActivities": -17060000,
"netCashProvidedByFinancingActivities": -168344000,
"effectOfForexChangesOnCash": 0,
"netChangeInCash": -304182000,
"cashAtEndOfPeriod": 814407000,
"cashAtBeginningOfPeriod": 1118589000,
"operatingCashFlow": -205479000,
"capitalExpenditure": -101972000,
"freeCashFlow": -307451000,
"incomeTaxesPaid": 37632000,
"interestPaid": 14913000
}
]
}
}
Data:
{
"price": 19.53,
"rsi": 67.78868940391942,
"sma20": 16.831500000000002,
"sma50": 17.145599999999998,
"sma200": 19.06900000000001,
"adx": 18.97426154178199,
"atr": 0.87,
"atr_pct": 4.45,
"high_52w": 163.85,
"low_52w": 11.93,
"structure": {
"ema8": 18.180524910066765,
"ema21": 17.479193111432043,
"ema50": 17.442424957767507,
"ema200": 22.073678116958654,
"checks": {
"price_above_all": false,
"ema_stacked": true,
"ema21_rising": true,
"ema50_rising": false,
"adx_over_30": false,
"higher_highs_lows": true,
"near_21ema": false
},
"dist_21ema_pct": 11.7,
"macd": {
"macd": 0.44,
"signal": 0.12,
"histogram": 0.32
},
"bollinger": {
"mid": 16.83,
"upper": 19.41,
"lower": 14.25,
"width_pct": 30.65
},
"crossover": {
"fresh_cross": true,
"pre_compressed": false,
"held_above_21": true,
"candles_since": 6,
"intraday_support": false
},
"momentum": {
"roc10": 22.6,
"checks": {
"roc_over_5": true,
"rsi_in_band": true,
"macd_expanding": true,
"top_quartile_3d": false,
"no_big_down": true,
"near_high": true
},
"volume": {
"rvol": 0.3,
"checks": {
"rvol_over_2": false,
"up_vol_beats_down": true,
"obv_new_high": false,
"surge_day": false,
"pullback_declining_vol": true,
"last_up_beats_down": false
}
}
},
"relative_strength": {
"sector": "Healthcare",
"sector_etf": "XLV",
"sector_etf_ret10d": 4.71,
"checks": {
"beats_spy_all": true,
"beats_sector_10d": true,
"rs_line_at_high": true,
"sector_top3": true
}
},
"commodity": {},
"universe": {
"checks": {
"price_over_20": false,
"avg_vol_over_2m": true,
"mcap_over_1b": true,
"no_earnings_7d": true,
"not_lev_etf_spac": true,
"bidask_spread": null,
"dollar_vol_over_10m": true
},
"avg_dollar_vol": 62771104.5,
"avg_vol": 3166260
},
"options": {
"checks": {
"call_vol_2x": false,
"ivr_under_40": true,
"iv_contracting": false,
"oi_calls_above_price": true
},
"vals": {
"call_vol_mult": 0.5,
"iv_rank": 14.0
}
}
}
}
Data:
{
"prior_day": {
"high": 20.19,
"low": 18.74,
"close": 19.84,
"date": "2026-08-19"
},
"woodie_pivots": {
"PP": 19.65,
"R1": 20.56,
"S1": 19.11,
"R2": 21.1,
"S2": 18.2
},
"swing": {
"high_20d": 20.19,
"low_20d": 14.75,
"high_60d": 20.88,
"low_60d": 14.68
},
"orb": {
"high": 19.33,
"low": 18.74,
"date": "2026-08-19"
},
"vwap": 19.58,
"volume_profile": {
"poc": 15.91,
"vah": 16.95,
"val": 14.87,
"sessions": 20
},
"premarket": {
"date": "2026-08-19",
"high": 18.74,
"low": 18.03,
"last": 18.74,
"volume": 23298,
"gap_pct": 4.0,
"path": "06:10 18.04 -> 06:55 18.03 -> 07:50 18.39 -> 08:00 18.33 -> 08:10 18.40 -> 08:50 18.50 -> 09:25 18.74",
"bars": 12,
"last_bar_et": "09:25"
},
"recent_daily": [
{
"d": "2026-07-16",
"o": 17.61,
"h": 17.815,
"l": 17.22,
"c": 17.23,
"v": 3180760.06161
},
{
"d": "2026-07-17",
"o": 16.66,
"h": 17.675,
"l": 16.65,
"c": 17.22,
"v": 5399159.894382
},
{
"d": "2026-07-20",
"o": 17.39,
"h": 17.7,
"l": 16.83,
"c": 16.83,
"v": 1777090.74708
},
{
"d": "2026-07-21",
"o": 16.81,
"h": 17.22,
"l": 16.02,
"c": 16.21,
"v": 4123318.646353
},
{
"d": "2026-07-22",
"o": 16.2,
"h": 16.37,
"l": 15.81,
"c": 15.82,
"v": 2426944.027103
},
{
"d": "2026-07-23",
"o": 15.57,
"h": 16.02,
"l": 15.43,
"c": 15.88,
"v": 2485535.180693
},
{
"d": "2026-07-24",
"o": 15.88,
"h": 16.03,
"l": 15.49,
"c": 15.68,
"v": 2141883.075191
},
{
"d": "2026-07-27",
"o": 16.46,
"h": 16.69,
"l": 15.88,
"c": 15.89,
"v": 3701422.474441
},
{
"d": "2026-07-28",
"o": 15.74,
"h": 15.975,
"l": 15.045,
"c": 15.43,
"v": 3533426.8062
},
{
"d": "2026-07-29",
"o": 15.43,
"h": 15.86,
"l": 15.085,
"c": 15.535,
"v": 2860568.910744
},
{
"d": "2026-07-30",
"o": 15.54,
"h": 15.65,
"l": 15.04,
"c": 15.56,
"v": 3024025.069327
},
{
"d": "2026-07-31",
"o": 15.5,
"h": 15.645,
"l": 14.84,
"c": 14.86,
"v": 3603368.128356
},
{
"d": "2026-08-03",
"o": 15.09,
"h": 15.89,
"l": 14.75,
"c": 15.88,
"v": 3799658.691439
},
{
"d": "2026-08-04",
"o": 16.005,
"h": 16.45,
"l": 15.64,
"c": 16.39,
"v": 2878687.241171
},
{
"d": "2026-08-05",
"o": 16.43,
"h": 16.755,
"l": 15.82,
"c": 15.93,
"v": 3109305.055676
},
{
"d": "2026-08-06",
"o": 16.66,
"h": 17.19,
"l": 16.3467,
"c": 16.78,
"v": 5241391.921137
},
{
"d": "2026-08-07",
"o": 16.865,
"h": 17.26,
"l": 16.47,
"c": 16.78,
"v": 3064146.075097
},
{
"d": "2026-08-10",
"o": 16.53,
"h": 17.21,
"l": 16.38,
"c": 17.18,
"v": 2696719.761406
},
{
"d": "2026-08-11",
"o": 17.23,
"h": 18.25,
"l": 17.23,
"c": 18.22,
"v": 3002762.456168
},
{
"d": "2026-08-12",
"o": 18.06,
"h": 18.485,
"l": 17.86,
"c": 18.38,
"v": 2369421.941943
},
{
"d": "2026-08-13",
"o": 18.41,
"h": 18.73,
"l": 18.2,
"c": 18.42,
"v": 2518301.38314
},
{
"d": "2026-08-14",
"o": 18.22,
"h": 18.26,
"l": 17.69,
"c": 18.1,
"v": 1561239.856804
},
{
"d": "2026-08-17",
"o": 17.93,
"h": 18.295,
"l": 17.724,
"c": 18.18,
"v": 1728692.093677
},
{
"d": "2026-08-18",
"o": 18.17,
"h": 18.29,
"l": 17.875,
"c": 18.02,
"v": 1600161.241919
},
{
"d": "2026-08-19",
"o": 18.74,
"h": 20.19,
"l": 18.74,
"c": 19.835,
"v": 1350656.758238
}
]
}
Data:
{
"estimates": [
{
"symbol": "SRPT",
"date": "2030-12-31",
"revenueLow": 1010080937,
"revenueHigh": 1430305251,
"revenueAvg": 1237029478,
"ebitdaLow": -452787346,
"ebitdaHigh": -319758224,
"ebitdaAvg": -391602628,
"ebitLow": -502799047,
"ebitHigh": -355076465,
"ebitAvg": -434856296,
"netIncomeLow": 16301599,
"netIncomeHigh": 25754975,
"netIncomeAvg": 21407114,
"sgaExpenseLow": 360658065,
"sgaExpenseHigh": 510702761,
"sgaExpenseAvg": 441691988,
"epsAvg": 0.20428,
"epsHigh": 0.24577,
"epsLow": 0.15556,
"numAnalystsRevenue": 6,
"numAnalystsEps": 4
},
{
"symbol": "SRPT",
"date": "2029-12-31",
"revenueLow": 1029314570,
"revenueHigh": 1457540659,
"revenueAvg": 1260584591,
"ebitdaLow": -461409176,
"ebitdaHigh": -325846956,
"ebitdaAvg": -399059398,
"ebitLow": -512373183,
"ebitHigh": -361837716,
"ebitAvg": -443136688,
"netIncomeLow": 17588457,
"netIncomeHigh": 27789008,
"netIncomeAvg": 23097425,
"sgaExpenseLow": 367525598,
"sgaExpenseHigh": 520427398,
"sgaExpenseAvg": 450102544,
"epsAvg": 0.22041,
"epsHigh": 0.26518,
"epsLow": 0.16784,
"numAnalystsRevenue": 11,
"numAnalystsEps": 4
},
{
"symbol": "SRPT",
"date": "2028-12-31",
"revenueLow": 784291635,
"revenueHigh": 1627737469,
"revenueAvg": 1332041525,
"ebitdaLow": -515287858,
"ebitdaHigh": -248280797,
"ebitdaAvg": -421680300,
"ebitLow": -572202925,
"ebitHigh": -275704145,
"ebitAvg": -468256136,
"netIncomeLow": -119645313,
"netIncomeHigh": 81476558,
"netIncomeAvg": -19084377.5,
"sgaExpenseLow": 280038057,
"sgaExpenseHigh": 581197629,
"sgaExpenseAvg": 475616855,
"epsAvg": 0.19864,
"epsHigh": 0.7775,
"epsLow": -1.14173,
"numAnalystsRevenue": 13,
"numAnalystsEps": 11
},
{
"symbol": "SRPT",
"date": "2027-12-31",
"revenueLow": 1249658558,
"revenueHigh": 1559651379,
"revenueAvg": 1414342245,
"ebitdaLow": -493734054,
"ebitdaHigh": -395600577,
"ebitdaAvg": -447733987,
"ebitLow": -548268439,
"ebitHigh": -439295830,
"ebitAvg": -497187529,
"netIncomeLow": 47462846,
"netIncomeHigh": 110929679,
"netIncomeAvg": 79196262.5,
"sgaExpenseLow": 446201310,
"sgaExpenseHigh": 556886906,
"sgaExpenseAvg": 505003033,
"epsAvg": 0.76364,
"epsHigh": 1.05856,
"epsLow": 0.45292,
"numAnalystsRevenue": 15,
"numAnalystsEps": 11
}
],
"price_target": {
"symbol": "SRPT",
"targetHigh": 35,
"targetLow": 14,
"targetConsensus": 25.11,
"targetMedian": 25
},
"ratings": {
"symbol": "SRPT",
"rating": "C+",
"overallScore": 2,
"discountedCashFlowScore": 5,
"returnOnEquityScore": 1,
"returnOnAssetsScore": 1,
"debtToEquityScore": 1,
"priceToEarningsScore": 1,
"priceToBookScore": 4
},
"grades": [
{
"symbol": "SRPT",
"date": "2026-07-09",
"gradingCompany": "Wolfe Research",
"previousGrade": "Peer Perform",
"newGrade": "Outperform",
"action": "upgrade"
},
{
"symbol": "SRPT",
"date": "2026-07-09",
"gradingCompany": "Piper Sandler",
"previousGrade": "Neutral",
"newGrade": "Neutral",
"action": "maintain"
},
{
"symbol": "SRPT",
"date": "2026-04-16",
"gradingCompany": "HC Wainwright & Co.",
"previousGrade": "Sell",
"newGrade": "Sell",
"action": "maintain"
},
{
"symbol": "SRPT",
"date": "2026-03-26",
"gradingCompany": "Needham",
"previousGrade": "Underperform",
"newGrade": "Underperform",
"action": "maintain"
},
{
"symbol": "SRPT",
"date": "2026-03-26",
"gradingCompany": "Citigroup",
"previousGrade": "Sell",
"newGrade": "Sell",
"action": "maintain"
},
{
"symbol": "SRPT",
"date": "2026-03-19",
"gradingCompany": "Oppenheimer",
"previousGrade": "Outperform",
"newGrade": "Outperform",
"action": "maintain"
},
{
"symbol": "SRPT",
"date": "2026-03-13",
"gradingCompany": "Mizuho",
"previousGrade": "Outperform",
"newGrade": "Outperform",
"action": "maintain"
},
{
"symbol": "SRPT",
"date": "2026-03-10",
"gradingCompany": "Citigroup",
"previousGrade": "Sell",
"newGrade": "Sell",
"action": "maintain"
},
{
"symbol": "SRPT",
"date": "2026-03-02",
"gradingCompany": "HC Wainwright & Co.",
"previousGrade": "Sell",
"newGrade": "Sell",
"action": "maintain"
},
{
"symbol": "SRPT",
"date": "2026-02-27",
"gradingCompany": "Wells Fargo",
"previousGrade": "Overweight",
"newGrade": "Overweight",
"action": "maintain"
},
{
"symbol": "SRPT",
"date": "2026-01-27",
"gradingCompany": "HC Wainwright & Co.",
"previousGrade": "Sell",
"newGrade": "Sell",
"action": "maintain"
},
{
"symbol": "SRPT",
"date": "2026-01-23",
"gradingCompany": "Wedbush",
"previousGrade": "Outperform",
"newGrade": "Outperform",
"action": "maintain"
},
{
"symbol": "SRPT",
"date": "2026-01-14",
"gradingCompany": "HC Wainwright & Co.",
"previousGrade": "Sell",
"newGrade": "Sell",
"action": "maintain"
},
{
"symbol": "SRPT",
"date": "2025-11-05",
"gradingCompany": "Barclays",
"previousGrade": "Equal Weight",
"newGrade": "Equal Weight",
"action": "maintain"
},
{
"symbol": "SRPT",
"date": "2025-11-05",
"gradingCompany": "Guggenheim",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
},
{
"symbol": "SRPT",
"date": "2025-11-05",
"gradingCompany": "Mizuho",
"previousGrade": "Neutral",
"newGrade": "Outperform",
"action": "upgrade"
},
{
"symbol": "SRPT",
"date": "2025-11-05",
"gradingCompany": "Wells Fargo",
"previousGrade": "Overweight",
"newGrade": "Overweight",
"action": "maintain"
},
{
"symbol": "SRPT",
"date": "2025-11-04",
"gradingCompany": "Baird",
"previousGrade": "Neutral",
"newGrade": "Neutral",
"action": "maintain"
},
{
"symbol": "SRPT",
"date": "2025-10-30",
"gradingCompany": "Piper Sandler",
"previousGrade": "Neutral",
"newGrade": "Neutral",
"action": "maintain"
},
{
"symbol": "SRPT",
"date": "2025-09-22",
"gradingCompany": "BMO Capital",
"previousGrade": "Market Perform",
"newGrade": "Outperform",
"action": "upgrade"
},
{
"symbol": "SRPT",
"date": "2025-09-15",
"gradingCompany": "Guggenheim",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
},
{
"symbol": "SRPT",
"date": "2025-09-09",
"gradingCompany": "Leerink Partners",
"previousGrade": "Market Perform",
"newGrade": "Market Perform",
"action": "maintain"
},
{
"symbol": "SRPT",
"date": "2025-08-25",
"gradingCompany": "HC Wainwright & Co.",
"previousGrade": "Sell",
"newGrade": "Sell",
"action": "maintain"
},
{
"symbol": "SRPT",
"date": "2025-08-21",
"gradingCompany": "B of A Securities",
"previousGrade": "Underperform",
"newGrade": "Underperform",
"action": "maintain"
},
{
"symbol": "SRPT",
"date": "2025-08-20",
"gradingCompany": "B of A Securities",
"previousGrade": "Underperform",
"newGrade": "Underperform",
"action": "maintain"
}
]
}
Data:
[
{
"title": "Bank of America Corp DE Increases Stock Position in Sarepta Therapeutics, Inc. $SRPT",
"url": "https://www.defenseworld.net/2026/08/13/bank-of-america-corp-de-increases-stock-position-in-sarepta-therapeutics-inc-srpt.html",
"source": "Defense World",
"date": "2026-08-13 03:38:41",
"summary": "Bank of America Corp DE increased its holdings in Sarepta Therapeutics, Inc. (NASDAQ: SRPT) by 26.6% in the undefined quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 2,145,926 shares of the biotechnology comp",
"image": "https://images.financialmodelingprep.com/news/bank-of-america-corp-de-increases-stock-position-in-20260813.png"
},
{
"title": "Sarepta's Q2 Earnings & Sales Beat Estimates, '26 Outlook Updated",
"url": "https://www.zacks.com/stock/news/2970349/sarepta-s-q2-earnings-sales-beat-estimates-26-outlook-updated?cid=CS-STOCKNEWSAPI-FT-analyst_blog|earnings_article-2970349",
"source": "Zacks Investment Research",
"date": "2026-08-06 15:06:06",
"summary": "SRPT beat Q2 earnings and revenue estimates despite weaker Elevidys sales, while narrowing its 2026 product revenue outlook and tightening expense guidance.",
"image": "https://images.financialmodelingprep.com/news/sareptas-q2-earnings-sales-beat-estimates-26-outlook-updated-20260806.jpg"
},
{
"title": "Sarepta Therapeutics Q2 Earnings Call Highlights",
"url": "https://www.marketbeat.com/instant-alerts/sarepta-therapeutics-q2-earnings-call-highlights-2026-08-06/",
"source": "MarketBeat",
"date": "2026-08-06 01:04:05",
"summary": "Sarepta Therapeutics NASDAQ: SRPT reported second-quarter 2026 total revenue of $401 million, down 34% from a year earlier, as lower ELEVIDYS sales weighed on results. The company nevertheless posted GAAP operating income of $13 million and non-GAAP operating income of $86 millio",
"image": "https://images.financialmodelingprep.com/news/sarepta-therapeutics-q2-earnings-call-highlights-20260806.jpg"
},
{
"title": "Sarepta Therapeutics, Inc. (SRPT) Q2 2026 Earnings Call Transcript",
"url": "https://seekingalpha.com/article/4931360-sarepta-therapeutics-inc-srpt-q2-2026-earnings-call-transcript",
"source": "Seeking Alpha",
"date": "2026-08-06 00:30:06",
"summary": "Sarepta Therapeutics, Inc. (SRPT) Q2 2026 Earnings Call Transcript",
"image": "https://images.financialmodelingprep.com/news/sarepta-therapeutics-inc-srpt-q2-2026-earnings-call-transcript-20260806.jpg"
},
{
"title": "Sarepta Therapeutics (SRPT) Q2 Earnings and Revenues Surpass Estimates",
"url": "https://www.zacks.com/stock/news/2969353/sarepta-therapeutics-srpt-q2-earnings-and-revenues-surpass-estimates?cid=CS-STOCKNEWSAPI-FT-fundamental_analysis|yseop_template_4-2969353",
"source": "Zacks Investment Research",
"date": "2026-08-05 21:36:35",
"summary": "Sarepta Therapeutics (SRPT) came out with quarterly earnings of $0.64 per share, beating the Zacks Consensus Estimate of $0.58 per share. This compares to earnings of $2.02 per share a year ago.",
"image": "https://images.financialmodelingprep.com/news/sarepta-therapeutics-srpt-q2-earnings-and-revenues-surpass-estimates-20260805.jpg"
},
{
"title": "Compared to Estimates, Sarepta Therapeutics (SRPT) Q2 Earnings: A Look at Key Metrics",
"url": "https://www.zacks.com/stock/news/2969438/compared-to-estimates-sarepta-therapeutics-srpt-q2-earnings-a-look-at-key-metrics?cid=CS-STOCKNEWSAPI-FT-fundamental_analysis|nfm-2969438",
"source": "Zacks Investment Research",
"date": "2026-08-05 21:31:05",
"summary": "While the top- and bottom-line numbers for Sarepta Therapeutics (SRPT) give a sense of how the business performed in the quarter ended June 2026, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.",
"image": "https://images.financialmodelingprep.com/news/compared-to-estimates-sarepta-therapeutics-srpt-q2-earnings-a-20260805.jpg"
},
{
"title": "Sarepta Therapeutics Announces Second Quarter 2026 Financial Results and Recent Corporate Developments",
"url": "https://www.businesswire.com/news/home/20260805692741/en/Sarepta-Therapeutics-Announces-Second-Quarter-2026-Financial-Results-and-Recent-Corporate-Developments/",
"source": "Business Wire",
"date": "2026-08-05 16:05:00",
"summary": "CAMBRIDGE, Mass.--(BUSINESS WIRE)--Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, today reported financial results for the second quarter of 2026. \u201cAs I begin my tenure as CEO, I am excited by the strength of Sarepta's founda",
"image": "https://images.financialmodelingprep.com/news/sarepta-therapeutics-announces-second-quarter-2026-financial-results-and-20260805.jpg"
},
{
"title": "Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)",
"url": "https://www.businesswire.com/news/home/20260729720331/en/Sarepta-Therapeutics-Announces-Inducement-Grants-Under-Nasdaq-Listing-Rule-5635-c-4/",
"source": "Business Wire",
"date": "2026-07-29 17:00:00",
"summary": "CAMBRIDGE, Mass.--(BUSINESS WIRE)--Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, granted equity awards on July 28, 2026, that were previously approved by its Board of Directors under Sarepta's 2024 Employment Commencement In",
"image": "https://images.financialmodelingprep.com/news/sarepta-therapeutics-announces-inducement-grants-under-nasdaq-listing-rule-20260729.jpg"
},
{
"title": "Earnings Preview: Sarepta Therapeutics (SRPT) Q2 Earnings Expected to Decline",
"url": "https://www.zacks.com/stock/news/2963355/earnings-preview-sarepta-therapeutics-srpt-q2-earnings-expected-to-decline?cid=CS-STOCKNEWSAPI-FT-tale_of_the_tape|yseop_template_9-2963355",
"source": "Zacks Investment Research",
"date": "2026-07-29 11:02:05",
"summary": "Sarepta Therapeutics (SRPT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.",
"image": "https://images.financialmodelingprep.com/news/earnings-preview-sarepta-therapeutics-srpt-q2-earnings-expected-to-20260729.jpg"
},
{
"title": "Sarepta names former Abbvie president as CEO as Ingram retires",
"url": "https://www.reuters.com/legal/transactional/sarepta-names-former-abbvie-president-ceo-ingram-retires-2026-07-27/",
"source": "Reuters",
"date": "2026-07-27 09:19:09",
"summary": "Sarepta Therapeutics said on Monday it appointed former Tessera Therapeutics CEO Michael \u200bSeverino its chief executive, effective July \u200c28. The longtime AbbVie executive, will succeed Doug Ingram.",
"image": "https://images.financialmodelingprep.com/news/sarepta-names-former-abbvie-president-as-ceo-as-ingram-20260727.jpg"
},
{
"title": "Sarepta Therapeutics Appoints Michael Severino, M.D., Chief Executive Officer",
"url": "https://www.businesswire.com/news/home/20260727284554/en/Sarepta-Therapeutics-Appoints-Michael-Severino-M.D.-Chief-Executive-Officer/",
"source": "Business Wire",
"date": "2026-07-27 08:30:00",
"summary": "CAMBRIDGE, Mass.--(BUSINESS WIRE)--Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, today announced the appointment of Michael Severino, M.D., as chief executive officer, effective July 28, 2026. Severino, who was previously CE",
"image": "https://images.financialmodelingprep.com/news/sarepta-therapeutics-appoints-michael-severino-md-chief-executive-officer-20260727.jpg"
},
{
"title": "SRPT Stock Slides 10% in a Week: Is Dyne Therapeutics a Threat?",
"url": "https://www.zacks.com/stock/news/2957998/srpt-stock-slides-10-in-a-week-is-dyne-therapeutics-a-threat?cid=CS-STOCKNEWSAPI-FT-analyst_blog|quick_take-2957998",
"source": "Zacks Investment Research",
"date": "2026-07-22 10:26:05",
"summary": "Sarepta falls nearly 10% in a week after Dyne Therapeutics wins FDA priority review for a rival DMD therapy that could challenge Exondys 51 if approved.",
"image": "https://images.financialmodelingprep.com/news/srpt-stock-slides-10-in-a-week-is-dyne-20260722.jpg"
},
{
"title": "Sarepta Therapeutics to Announce Second Quarter 2026 Financial Results",
"url": "https://www.businesswire.com/news/home/20260722909703/en/Sarepta-Therapeutics-to-Announce-Second-Quarter-2026-Financial-Results/",
"source": "Business Wire",
"date": "2026-07-22 08:30:00",
"summary": "CAMBRIDGE, Mass.--(BUSINESS WIRE)--Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, will report second quarter 2026 financial results after the Nasdaq Global Market closes on Wednesday, Aug. 5, 2026. Subsequently, at 4:30 p.m. ",
"image": "https://images.financialmodelingprep.com/news/sarepta-therapeutics-to-announce-second-quarter-2026-financial-results-20260722.jpg"
},
{
"title": "Johnson Fistel, PLLP Investigates Claims on Behalf of Long-Term Shareholders of Sarepta Therapeutics, Inc. (SRPT)",
"url": "https://www.globenewswire.com/news-release/2026/07/13/3326258/0/en/Johnson-Fistel-PLLP-Investigates-Claims-on-Behalf-of-Long-Term-Shareholders-of-Sarepta-Therapeutics-Inc-SRPT.html",
"source": "GlobeNewsWire",
"date": "2026-07-13 09:46:00",
"summary": "SAN DIEGO, July 13, 2026 (GLOBE NEWSWIRE) -- Johnson Fistel, PLLP is investigating potential claims on behalf of current, long-term shareholders of Sarepta Therapeutics, Inc. (NASDAQ: SRPT) against certain of its officers and directors for alleged breaches of fiduciary duty.",
"image": "https://images.financialmodelingprep.com/news/johnson-fistel-pllp-investigates-claims-on-behalf-of-longterm-20260713.jpg"
},
{
"title": "2 Beaten-Down Stocks That Still Aren't Worth Buying",
"url": "https://www.fool.com/investing/2026/07/11/2-beaten-down-stocks-that-still-arent-worth-buying/?source=iedfolrf0000001",
"source": "The Motley Fool",
"date": "2026-07-11T20:30:00Z",
"summary": "The article argues that Recursion Pharmaceuticals and Sarepta Therapeutics, despite significant stock declines, remain unattractive investments. Recursion has no approved products and faces competition in AI-driven drug discovery. Sarepta struggles with safety concerns around its",
"image": "https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F878262%2Fperson-looking-at-multiple-monitors.jpg&w=1200&op=resize"
},
{
"title": "My Top 3 Biotech Stocks for May 2026",
"url": "https://www.fool.com/investing/2026/05/20/my-top-3-biotech-stocks-for-may-2026/?source=iedfolrf0000001",
"source": "The Motley Fool",
"date": "2026-05-20T15:15:00Z",
"summary": "With stabilizing interest rates and increased FDA activity, three biotech companies stand out: Schr\u00f6dinger combines AI-driven drug discovery with established software revenue ($256M in 2025); Sarepta generates nearly $2B in annual product revenue from gene therapy despite ongoing",
"image": "https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F869512%2Flab-worker-woman-science-research.jpg&w=1200&op=resize"
},
{
"title": "Protein Synthesis Research Market to Reach $42.8 Billion by 2031, Driven by Surging CGT Investment",
"url": "https://www.globenewswire.com/news-release/2026/05/18/3296974/0/en/Protein-Synthesis-Research-Market-to-Reach-42-8-Billion-by-2031-Driven-by-Surging-CGT-Investment.html",
"source": "GlobeNewswire Inc.",
"date": "2026-05-18T18:33:00Z",
"summary": "The global protein synthesis research market is experiencing accelerating growth driven by increased investment in cell and gene therapy research, rising chronic disease prevalence, and expanding healthcare budgets. North America leads with 42.8% market share, while Asia-Pacific ",
"image": "https://ml.globenewswire.com/Resource/Download/d0c282b6-d496-45a8-a941-33fa5c3e824c"
},
{
"title": "Nasdaq 100 Enters Correction As 30-Year Yields Near 5%: What's Moving Markets Friday?",
"url": "https://www.benzinga.com/markets/equities/26/03/51517275/iran-oil-price-today-nasdaq-correction-inflation-treasury-yields-stock-market-news-today-friday?utm_source=benzinga_taxonomy&utm_medium=rss_feed_free&utm_content=taxonomy_rss&utm_campaign=channel",
"source": "Benzinga",
"date": "2026-03-27T17:09:48Z",
"summary": "U.S. equities tumbled to their lowest levels in nearly seven months on Friday as the Nasdaq 100 officially entered correction territory, down over 10% from January highs. The decline was driven by geopolitical tensions with Iran rejecting ceasefire options, surging crude oil pric",
"image": "https://cdn.benzinga.com/files/images/story/2026/03/27/Nasdaq-100-way-down.jpeg?width=1200&height=800&fit=crop"
},
{
"title": "Stock Market Today: Dow Futures Gain, S&P 500 Slips As Investors Brace For Mega-Cap Earnings\u2014 Brand Engagement, Nucor In Focus (UPDATED)",
"url": "https://www.benzinga.com/markets/equities/26/01/50120802/stock-market-today-dow-jones-sp-500-futures-slip-as-investors-brace-for-mega-cap-earnings-brand-?utm_source=benzinga_taxonomy&utm_medium=rss_feed_free&utm_content=taxonomy_rss&utm_campaign=channel",
"source": "Benzinga",
"date": "2026-01-26T13:41:56Z",
"summary": "U.S. stock futures declined on Monday as investors await mega-cap earnings from tech giants and other major companies. The market is also bracing for the Federal Reserve's interest rate decision on Wednesday, with markets pricing in a 97.2% likelihood of unchanged rates. Key move",
"image": "https://cdn.benzinga.com/files/images/story/2026/01/26/Wall-Street.jpeg?width=1200&height=800&fit=crop"
},
{
"title": "2 Beaten-Down Stocks That Could Sink Even More in 2026",
"url": "https://www.fool.com/investing/2026/01/21/2-beaten-down-stocks-that-could-sink-even-more-in/?source=iedfolrf0000001",
"source": "The Motley Fool",
"date": "2026-01-22T03:30:00Z",
"summary": "Sarepta Therapeutics and Teladoc Health are identified as two stocks likely to continue declining in 2026. Sarepta faces significant headwinds from safety concerns with its flagship DMD treatment Elevidys, which caused patient deaths and led to restricted access. Teladoc Health s",
"image": "https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F851531%2Fdoctor-and-patient-in-a-hospital-room.jpg&w=1200&op=resize"
},
{
"title": "Silver Breaks Above $70, Novo Nordisk Soars 9% On Obesity Pill Approval: What's Moving Markets Tuesday? (CORRECTED)",
"url": "https://www.benzinga.com/markets/equities/25/12/49569259/markets-today-stock-market-news-tuesday-wall-street-index-performance-silver-novo-nordisk?utm_source=benzinga_taxonomy&utm_medium=rss_feed_free&utm_content=taxonomy_rss&utm_campaign=channel",
"source": "Benzinga",
"date": "2025-12-24T14:14:19Z",
"summary": "Wall Street traded modestly higher Tuesday with the S&P 500 up 0.4% near 6,900. Strong U.S. GDP data (4.3% annualized growth) prompted traders to scale back Fed rate cut expectations. Novo Nordisk surged 9% following FDA approval of Wegovy in pill form. Precious metals rallied si",
"image": "https://cdn.benzinga.com/files/images/story/2025/12/24/Silver-Bars.jpeg?width=1200&height=800&fit=crop"
},
{
"title": "Sarepta Stock Dumps: Pharma Bro Martin Shkreli Still Likes It",
"url": "https://www.benzinga.com/trading-ideas/movers/25/11/48628604/sarepta-stock-dumps-pharma-bro-martin-shkreli-still-likes-it?utm_source=benzinga_taxonomy&utm_medium=rss_feed_free&utm_content=taxonomy_rss&utm_campaign=channel",
"source": "Benzinga",
"date": "2025-11-04T17:11:10Z",
"summary": "Sarepta Therapeutics experienced a significant stock drop of over 33% after its Phase 3 ESSENCE study for Duchenne muscular dystrophy treatments failed to meet primary endpoints, raising concerns about its drug pipeline and gene therapy safety.",
"image": "https://cdn.benzinga.com/files/images/story/2025/11/04/Konskie--Poland---February-24--2024-Sare.jpeg?width=1200&height=800&fit=crop"
},
{
"title": "AAV Gene Therapy Market Size to Skyrocket at 40.1% CAGR by 2034",
"url": "https://www.globenewswire.com/news-release/2025/10/07/3162748/0/en/AAV-Gene-Therapy-Market-Size-to-Skyrocket-at-40-1-CAGR-by-2034.html",
"source": "GlobeNewswire Inc.",
"date": "2025-10-07T15:00:00Z",
"summary": "The AAV gene therapy market is projected to grow from $3.85 billion in 2025 to $78.56 billion by 2034, with a 40.1% CAGR. North America leads the market, driven by research investments, technological advancements, and increasing genetic disorder prevalence.",
"image": "https://ml.globenewswire.com/Resource/Download/01eb1f79-0c67-420b-b423-376619f975cd"
},
{
"title": "2 Beaten-Down Stocks to Avoid Right Now",
"url": "https://www.fool.com/investing/2025/09/05/2-beaten-down-stocks-to-avoid-right-now/?source=iedfolrf0000001",
"source": "The Motley Fool",
"date": "2025-09-05T13:30:00Z",
"summary": "The article analyzes two healthcare stocks, Teladoc and Sarepta Therapeutics, highlighting significant challenges that make them unattractive investment options, including revenue decline, profitability issues, and safety concerns with medical treatments.",
"image": "https://g.foolcdn.com/editorial/images/831224/patient-on-a-telehealth-consultation.jpg"
},
{
"title": "SRPT Stock Alert: Investors with Large Losses Should Contact Robbins LLP for Information About the Pending Lead Plaintiff Deadline in the Sarepta Therapeutics, Inc. Class Action",
"url": "https://www.globenewswire.com/news-release/2025/08/29/3141753/32719/en/SRPT-Stock-Alert-Investors-with-Large-Losses-Should-Contact-Robbins-LLP-for-Information-About-the-Pending-Lead-Plaintiff-Deadline-in-the-Sarepta-Therapeutics-Inc-Class-Action.html",
"source": "GlobeNewswire Inc.",
"date": "2025-08-29T19:13:00Z",
"summary": "Sarepta Therapeutics faces a class action lawsuit alleging misleading investors about safety risks of its ELEVIDYS gene therapy for Duchenne muscular dystrophy, with two patient deaths and FDA investigation leading to significant stock price drops.",
"image": "https://ml.globenewswire.com/Resource/Download/f6c754ad-b344-4389-a551-cf97ce05752e"
}
]
Data:
[
{
"symbol": "SRPT",
"date": "2026-11-04",
"epsActual": null,
"epsEstimated": 0.3897,
"revenueActual": null,
"revenueEstimated": 353807400,
"lastUpdated": "2026-08-19"
},
{
"symbol": "SRPT",
"date": "2026-08-05",
"epsActual": -0.05,
"epsEstimated": 0.2173,
"revenueActual": 401251000,
"revenueEstimated": 366391700,
"lastUpdated": "2026-08-19"
},
{
"symbol": "SRPT",
"date": "2026-05-06",
"epsActual": 3.16,
"epsEstimated": 0.976,
"revenueActual": 730803000,
"revenueEstimated": 474155400,
"lastUpdated": "2026-08-06"
},
{
"symbol": "SRPT",
"date": "2026-02-25",
"epsActual": -3.58,
"epsEstimated": -1.03,
"revenueActual": 442934000,
"revenueEstimated": 369600000,
"lastUpdated": "2026-05-25"
},
{
"symbol": "SRPT",
"date": "2025-11-03",
"epsActual": -1.8,
"epsEstimated": -0.72697,
"revenueActual": 399356000,
"revenueEstimated": 335761400,
"lastUpdated": "2026-08-18"
}
]
Data:
{
"borrow": [],
"short_interest": [
{
"symbol": "SRPT",
"file_date": "",
"error": "Symbol not found in FINRA biweekly file",
"days_to_cover": null
}
],
"ftd": {
"symbol": "SRPT",
"periods": [
{
"file_period": "202604a",
"settlement_date": "20260409",
"quantity_fails": 49880,
"price": 21.9
},
{
"file_period": "202604b",
"settlement_date": "20260429",
"quantity_fails": 226,
"price": 21.07
},
{
"file_period": "202606a",
"settlement_date": "20260608",
"quantity_fails": 23975,
"price": 15.75
},
{
"file_period": "202606b",
"settlement_date": "20260629",
"quantity_fails": 19293,
"price": 16.85
},
{
"file_period": "202607a",
"settlement_date": "20260710",
"quantity_fails": 38267,
"price": 20.52
},
{
"file_period": "202607b",
"settlement_date": "20260731",
"quantity_fails": 5930,
"price": 15.56
}
],
"trend": "falling",
"trend_description": "FTD quantity declining \u2014 shorts covering or delivery improving"
}
}
Data:
{
"insider": [
{
"symbol": "SRPT",
"filingDate": "2026-07-29",
"transactionDate": "2026-07-28",
"reportingCik": "0001609447",
"companyCik": "0000873303",
"transactionType": "A-Award",
"securitiesOwned": 2224342,
"reportingName": "SEVERINO MICHAEL",
"typeOfOwner": "director, officer: Chief Executive Officer",
"acquisitionOrDisposition": "A",
"directOrIndirect": "D",
"formType": "4",
"securitiesTransacted": 2224342,
"price": 17.74,
"securityName": "Stock Options (right to buy)",
"url": "https://www.sec.gov/Archives/edgar/data/873303/000119312526324445/0001193125-26-324445-index.htm"
},
{
"symbol": "SRPT",
"filingDate": "2026-07-29",
"transactionDate": "2026-07-28",
"reportingCik": "0001609447",
"companyCik": "0000873303",
"transactionType": "A-Award",
"securitiesOwned": 756104,
"reportingName": "SEVERINO MICHAEL",
"typeOfOwner": "director, officer: Chief Executive Officer",
"acquisitionOrDisposition": "A",
"directOrIndirect": "D",
"formType": "4",
"securitiesTransacted": 756104,
"price": 0,
"securityName": "Common Stock",
"url": "https://www.sec.gov/Archives/edgar/data/873303/000119312526324445/0001193125-26-324445-index.htm"
},
{
"symbol": "SRPT",
"filingDate": "2026-07-29",
"transactionDate": "2026-07-28",
"reportingCik": "0001609447",
"companyCik": "0000873303",
"transactionType": "",
"securitiesOwned": 0,
"reportingName": "SEVERINO MICHAEL",
"typeOfOwner": "",
"acquisitionOrDisposition": "",
"directOrIndirect": null,
"formType": "3",
"securitiesTransacted": 0,
"price": 0,
"securityName": "",
"url": "https://www.sec.gov/Archives/edgar/data/873303/000119312526324437/0001193125-26-324437-index.htm"
},
{
"symbol": "SRPT",
"filingDate": "2026-06-05",
"transactionDate": "2026-06-04",
"reportingCik": "0001761826",
"companyCik": "0000873303",
"transactionType": "A-Award",
"securitiesOwned": 25138,
"reportingName": "Boor Kathryn Jean",
"typeOfOwner": "director",
"acquisitionOrDisposition": "A",
"directOrIndirect": "D",
"formType": "4",
"securitiesTransacted": 16875,
"price": 0,
"securityName": "Common Stock",
"url": "https://www.sec.gov/Archives/edgar/data/873303/000119312526260263/0001193125-26-260263-index.htm"
},
{
"symbol": "SRPT",
"filingDate": "2026-06-05",
"transactionDate": "2026-06-04",
"reportingCik": "0001849061",
"companyCik": "0000873303",
"transactionType": "A-Award",
"securitiesOwned": 18640,
"reportingName": "Mayo Stephen",
"typeOfOwner": "director",
"acquisitionOrDisposition": "A",
"directOrIndirect": "D",
"formType": "4",
"securitiesTransacted": 16875,
"price": 0,
"securityName": "Common Stock",
"url": "https://www.sec.gov/Archives/edgar/data/873303/000119312526260261/0001193125-26-260261-index.htm"
},
{
"symbol": "SRPT",
"filingDate": "2026-06-05",
"transactionDate": "2026-06-04",
"reportingCik": "0001492766",
"companyCik": "0000873303",
"transactionType": "A-Award",
"securitiesOwned": 42098,
"reportingName": "Wigzell Hans Lennart Rudolf",
"typeOfOwner": "director",
"acquisitionOrDisposition": "A",
"directOrIndirect": "D",
"formType": "4",
"securitiesTransacted": 16875,
"price": 0,
"securityName": "Common Stock",
"url": "https://www.sec.gov/Archives/edgar/data/873303/000119312526260259/0001193125-26-260259-index.htm"
},
{
"symbol": "SRPT",
"filingDate": "2026-06-05",
"transactionDate": "2026-06-04",
"reportingCik": "0001211701",
"companyCik": "0000873303",
"transactionType": "A-Award",
"securitiesOwned": 214357,
"reportingName": "BEHRENS M KATHLEEN",
"typeOfOwner": "director",
"acquisitionOrDisposition": "A",
"directOrIndirect": "D",
"formType": "4",
"securitiesTransacted": 16875,
"price": 0,
"securityName": "Common Stock",
"url": "https://www.sec.gov/Archives/edgar/data/873303/000119312526260257/0001193125-26-260257-index.htm"
},
{
"symbol": "SRPT",
"filingDate": "2026-06-05",
"transactionDate": "2026-06-04",
"reportingCik": "0001303417",
"companyCik": "0000873303",
"transactionType": "A-Award",
"securitiesOwned": 22100,
"reportingName": "Connelly Deirdre P",
"typeOfOwner": "director",
"acquisitionOrDisposition": "A",
"directOrIndirect": "D",
"formType": "4",
"securitiesTransacted": 16875,
"price": 0,
"securityName": "Common Stock",
"url": "https://www.sec.gov/Archives/edgar/data/873303/000119312526260255/0001193125-26-260255-index.htm"
}
],
"congress": [
"status",
"endpoint",
"provided",
"message",
{
"symbol": "SRPT",
"senateID": "G000583",
"disclosureDate": "2023-08-21",
"transactionDate": "2023-07-14",
"firstName": "Josh",
"lastName": "Gottheimer",
"office": "Josh Gottheimer",
"district": "NJ05",
"owner": "Joint",
"assetDescription": "Sarepta Therapeutics, Inc. (SRPT)",
"assetType": "Stock",
"type": "Purchase",
"amount": "$1,001 - $15,000",
"capitalGainsOver200USD": "False",
"comment": "",
"link": "https://disclosures-clerk.house.gov/public_disc/ptr-pdfs/2023/20023500.pdf"
},
{
"symbol": "SRPT",
"senateID": "G000583",
"disclosureDate": "2023-07-11",
"transactionDate": "2023-06-13",
"firstName": "Josh",
"lastName": "Gottheimer",
"office": "Josh Gottheimer",
"district": "NJ05",
"owner": "Joint",
"assetDescription": "Sarepta Therapeutics, Inc. (SRPT)",
"assetType": "Stock",
"type": "Sale (Full)",
"amount": "$1,001 - $15,000",
"capitalGainsOver200USD": "False",
"comment": "",
"link": "https://disclosures-clerk.house.gov/public_disc/ptr-pdfs/2023/20023257.pdf"
},
{
"symbol": "SRPT",
"senateID": "D000625",
"disclosureDate": "2023-05-19",
"transactionDate": "2023-04-10",
"firstName": "Daniel",
"lastName": "Goldman",
"office": "Daniel Goldman",
"district": "NY10",
"owner": "",
"assetDescription": "Sarepta Therapeutics Inc",
"assetType": "Stock",
"type": "Sale",
"amount": "$15,001 - $50,000",
"capitalGainsOver200USD": "False",
"comment": "",
"link": "https://disclosures-clerk.house.gov/public_disc/ptr-pdfs/2023/20022948.pdf"
},
{
"symbol": "SRPT",
"senateID": "G000583",
"disclosureDate": "2023-04-20",
"transactionDate": "2023-03-06",
"firstName": "Josh",
"lastName": "Gottheimer",
"office": "Josh Gottheimer",
"district": "NJ05",
"owner": "Joint",
"assetDescription": "Sarepta Therapeutics, Inc.",
"assetType": "Stock",
"type": "Purchase",
"amount": "$1,001 - $15,000",
"capitalGainsOver200USD": "False",
"comment": "",
"link": "https://disclosures-clerk.house.gov/public_disc/ptr-pdfs/2023/20022683.pdf"
},
{
"symbol": "SRPT",
"senateID": "D000625",
"disclosureDate": "2023-04-17",
"transactionDate": "2023-03-06",
"firstName": "Daniel",
"lastName": "Goldman",
"office": "Daniel Goldman",
"district": "NY10",
"owner": "",
"assetDescription": "Sarepta Therapeutics, Inc.",
"assetType": "Stock",
"type": "Purchase",
"amount": "$15,001 - $50,000",
"capitalGainsOver200USD": "False",
"comment": "",
"link": "https://disclosures-clerk.house.gov/public_disc/ptr-pdfs/2023/20022653.pdf"
},
{
"symbol": "SRPT",
"senateID": "D000625",
"disclosureDate": "2023-02-24",
"transactionDate": "2023-01-31",
"firstName": "Daniel",
"lastName": "Goldman",
"office": "Daniel Goldman",
"district": "NY10",
"owner": "",
"assetDescription": "Sarepta Therapeutics Inc",
"assetType": "Stock",
"type": "Sale",
"amount": "$1,001 - $15,000",
"capitalGainsOver200USD": "False",
"comment": "",
"link": "https://disclosures-clerk.house.gov/public_disc/ptr-pdfs/2023/20022407.pdf"
},
{
"symbol": "SRPT",
"senateID": "G000583",
"disclosureDate": "2020-12-09",
"transactionDate": "2020-11-06",
"firstName": "Josh",
"lastName": "Gottheimer",
"office": "Josh Gottheimer",
"district": "NJ05",
"owner": "Joint",
"assetDescription": "Sarepta Therapeutics, Inc.",
"assetType": "Stock",
"type": "Sale (Full)",
"amount": "$1,001 - $15,000",
"capitalGainsOver200USD": "False",
"comment": "",
"link": "https://disclosures-clerk.house.gov/public_disc/ptr-pdfs/2020/20017827.pdf"
},
{
"symbol": "SRPT",
"senateID": "C001123",
"disclosureDate": "2020-10-14",
"transactionDate": "2020-09-14",
"firstName": "Gilbert",
"lastName": "Cisneros",
"office": "Gilbert Cisneros",
"district": "CA31",
"owner": "",
"assetDescription": "Sarepta Therapeutics, Inc.",
"assetType": "Stock",
"type": "Purchase",
"amount": "$1,001 - $15,000",
"capitalGainsOver200USD": "False",
"comment": "",
"link": "https://disclosures-clerk.house.gov/public_disc/ptr-pdfs/2020/20017505.pdf"
},
{
"symbol": "SRPT",
"senateID": "C001123",
"disclosureDate": "2020-07-17",
"transactionDate": "2020-06-10",
"firstName": "Gilbert",
"lastName": "Cisneros",
"office": "Gilbert Cisneros",
"district": "CA31",
"owner": "",
"assetDescription": "Sarepta Therapeutics, Inc.",
"assetType": "Stock",
"type": "Sale (Partial)",
"amount": "$1,001 - $15,000",
"capitalGainsOver200USD": "True",
"comment": "",
"link": "https://disclosures-clerk.house.gov/public_disc/ptr-pdfs/2020/20016915.pdf"
},
{
"symbol": "SRPT",
"senateID": "G000583",
"disclosureDate": "2020-01-06",
"transactionDate": "2019-12-13",
"firstName": "Josh",
"lastName": "Gottheimer",
"office": "Josh Gottheimer",
"district": "NJ05",
"owner": "Joint",
"assetDescription": "Sarepta Therapeutics, Inc. (SRPT)",
"assetType": "Stock",
"type": "Purchase",
"amount": "$1,001 - $15,000",
"capitalGainsOver200USD": "False",
"comment": "",
"link": "https://disclosures-clerk.house.gov/public_disc/ptr-pdfs/2020/20013859.pdf"
}
],
"dark_pool": [
{
"ticker": "SRPT",
"executed_at": "2026-08-19T14:38:16.941000Z",
"size": 1404.0,
"price": 19.8,
"premium": 27799.2,
"volume": 1404.0,
"trade_code": "F"
},
{
"ticker": "SRPT",
"executed_at": "2026-08-19T14:38:09.846000Z",
"size": 900.0,
"price": 19.845,
"premium": 17860.5,
"volume": 900.0,
"trade_code": " "
},
{
"ticker": "SRPT",
"executed_at": "2026-08-19T14:38:01.205000Z",
"size": 700.0,
"price": 19.76,
"premium": 13832.000000000002,
"volume": 700.0,
"trade_code": "F"
},
{
"ticker": "SRPT",
"executed_at": "2026-08-19T14:38:05.426000Z",
"size": 400.0,
"price": 19.8,
"premium": 7920.0,
"volume": 400.0,
"trade_code": " "
},
{
"ticker": "SRPT",
"executed_at": "2026-08-19T14:38:05.425000Z",
"size": 400.0,
"price": 19.8,
"premium": 7920.0,
"volume": 400.0,
"trade_code": " "
},
{
"ticker": "SRPT",
"executed_at": "2026-08-19T14:38:05.425000Z",
"size": 400.0,
"price": 19.8,
"premium": 7920.0,
"volume": 400.0,
"trade_code": " "
},
{
"ticker": "SRPT",
"executed_at": "2026-08-19T14:38:05.425000Z",
"size": 400.0,
"price": 19.8,
"premium": 7920.0,
"volume": 400.0,
"trade_code": " "
},
{
"ticker": "SRPT",
"executed_at": "2026-08-19T14:38:05.426000Z",
"size": 300.0,
"price": 19.8,
"premium": 5940.0,
"volume": 300.0,
"trade_code": " "
}
],
"ats": {
"symbol": "SRPT",
"date": "20260818",
"ats_volume": 0,
"total_volume": 457292,
"ats_ratio": 0.0,
"ats_pct": 0.0,
"signal": "Low",
"history": [
{
"date": "20260818",
"ats_ratio": 0.0
},
{
"date": "20260817",
"ats_ratio": 0.0
},
{
"date": "20260814",
"ats_ratio": 0.0
},
{
"date": "20260813",
"ats_ratio": 0.0
},
{
"date": "20260812",
"ats_ratio": 0.0
}
]
},
"polygon_dp": {
"ticker": "SRPT",
"days": [
{
"date": "2026-08-19",
"close": 19.835,
"vwap": 19.56,
"volume": 1350656,
"vwap_discount_pct": -1.4
},
{
"date": "2026-08-18",
"close": 18.02,
"vwap": 18.02,
"volume": 1600161,
"vwap_discount_pct": -0.02
},
{
"date": "2026-08-17",
"close": 18.18,
"vwap": 18.12,
"volume": 1728692,
"vwap_discount_pct": -0.33
},
{
"date": "2026-08-14",
"close": 18.1,
"vwap": 17.96,
"volume": 1561239,
"vwap_discount_pct": -0.75
},
{
"date": "2026-08-13",
"close": 18.42,
"vwap": 18.43,
"volume": 2518301,
"vwap_discount_pct": 0.03
}
],
"avg_vwap_discount_pct": -0.49,
"signal": "Distribution"
},
"options_flow": [
{
"price": "7.50",
"nbbo_ask": "8.80",
"nbbo_bid": "7.50",
"size": 17,
"implied_volatility": "0.822273993900994",
"open_interest": 541,
"option_chain_id": "SRPT280121C00020000",
"strike": "20",
"executed_at": "2026-08-19T14:20:52.939327Z",
"expiry": "2028-01-21",
"sector": "Healthcare",
"volume": 18,
"option_type": "call",
"premium": "12750.00",
"underlying_price": "19.43",
"underlying_symbol": "SRPT",
"delta": "0.699196064298718"
}
],
"net_premium": {
"ticker": "SRPT",
"net_call_premium": "123997.00",
"net_put_premium": "-2666.00",
"call_premium": "286612.00",
"put_premium": "23317.00",
"bullish_premium": "211666.00",
"bearish_premium": "85003.00",
"put_call_ratio": "0.09507042253521126761",
"iv_rank": "14.4548",
"implied_move_perc": "0.124000",
"gex_ratio": "0.38986988510102965871",
"gex_net_change": "-5340.4194",
"gex_call": "272465.0004",
"gex_put": "-106225.8984",
"gex_net": 166239.102,
"gex_call_delta": "1860970.0362",
"gex_put_delta": "-833791.0361",
"gex_date": "2026-08-19"
},
"hot_chains": [
{
"underlying_symbol": "SRPT",
"expires": "2026-08-21",
"open_interest": 3410,
"option_type": "call",
"delta": 0.460135152538295,
"ask_volume": 208,
"last_price": "0.45",
"implied_volatility": "0.891442397968199",
"gamma": 0.337610441850171,
"avg_price": "0.2873040752351097178683385578",
"bid_volume": 51,
"nbbo_ask": "0.55",
"strike": "20",
"option_symbol": "SRPT260821C00020000",
"total_premium": "9165.00",
"iv": 0.759015580708175,
"volume": 319,
"nbbo_bid": "0.30"
},
{
"underlying_symbol": "SRPT",
"expires": "2026-08-21",
"open_interest": 1917,
"option_type": "call",
"delta": 0.988263454801408,
"ask_volume": 102,
"last_price": "1.95",
"implied_volatility": "0.979456982173217",
"gamma": 0.0274468806002897,
"avg_price": "1.9299319727891156462585034013",
"bid_volume": 42,
"nbbo_ask": "2.00",
"strike": "17.5",
"option_symbol": "SRPT260821C00017500",
"total_premium": "28370.00",
"iv": 0.720609078690391,
"volume": 147,
"nbbo_bid": "1.75"
},
{
"underlying_symbol": "SRPT",
"expires": "2026-08-28",
"open_interest": 250,
"option_type": "call",
"delta": 0.585392245037406,
"ask_volume": 131,
"last_price": "0.90",
"implied_volatility": "0.645427316142239",
"gamma": 0.1792185065002396,
"avg_price": "0.8904411764705882352941176469",
"bid_volume": 5,
"nbbo_ask": "1.50",
"strike": "19.5",
"option_symbol": "SRPT260828C00019500",
"total_premium": "12110.00",
"iv": 0.689332084275544,
"volume": 136,
"nbbo_bid": "0.85"
},
{
"underlying_symbol": "SRPT",
"expires": "2027-02-19",
"open_interest": 161,
"option_type": "call",
"delta": 0.507887150034674,
"ask_volume": 117,
"last_price": "3.28",
"implied_volatility": "0.748754480532581",
"gamma": 0.0385669343909014,
"avg_price": "3.4788983050847457627118644068",
"bid_volume": 1,
"nbbo_ask": "3.50",
"strike": "22.5",
"option_symbol": "SRPT270219C00022500",
"total_premium": "41051.00",
"iv": 0.733402105100527,
"volume": 118,
"nbbo_bid": "2.65"
},
{
"underlying_symbol": "SRPT",
"expires": "2027-01-15",
"open_interest": 2212,
"option_type": "call",
"delta": 0.599224865927821,
"ask_volume": 56,
"last_price": "4.00",
"implied_volatility": "0.751802928465116",
"gamma": 0.0366370052835005,
"avg_price": "3.5146341463414634146341463415",
"bid_volume": 26,
"nbbo_ask": "5.00",
"strike": "20",
"option_symbol": "SRPT270115C00020000",
"total_premium": "28820.00",
"iv": 0.831279072334286,
"volume": 82,
"nbbo_bid": "3.90"
},
{
"underlying_symbol": "SRPT",
"expires": "2026-09-04",
"open_interest": 0,
"option_type": "call",
"delta": 0.575829625642504,
"ask_volume": 45,
"last_price": "1.10",
"implied_volatility": "0.636647292264185",
"gamma": 0.1272367002201777,
"avg_price": "1.0712328767123287671232876710",
"bid_volume": 27,
"nbbo_ask": "1.30",
"strike": "19.5",
"option_symbol": "SRPT260904C00019500",
"total_premium": "7820.00",
"iv": 0.735762039017837,
"volume": 73,
"nbbo_bid": "0.90"
},
{
"underlying_symbol": "SRPT",
"expires": "2026-09-04",
"open_interest": 11,
"option_type": "call",
"delta": 0.51010822646271,
"ask_volume": 0,
"last_price": "0.85",
"implied_volatility": "0.593459833308756",
"gamma": 0.1323097134781104,
"avg_price": "0.8500000000000000000000000000",
"bid_volume": 69,
"nbbo_ask": "1.45",
"strike": "20",
"option_symbol": "SRPT260904C00020000",
"total_premium": "5865.00",
"iv": 0.720377169632467,
"volume": 69,
"nbbo_bid": "0.65"
},
{
"underlying_symbol": "SRPT",
"expires": "2027-01-15",
"open_interest": 2217,
"option_type": "call",
"delta": 0.41176306126939,
"ask_volume": 50,
"last_price": "2.00",
"implied_volatility": "0.729098833801562",
"gamma": 0.0398438387249068,
"avg_price": "1.9289552238805970149253731344",
"bid_volume": 17,
"nbbo_ask": "2.75",
"strike": "25",
"option_symbol": "SRPT270115C00025000",
"total_premium": "12924.00",
"iv": 0.769526673233869,
"volume": 67,
"nbbo_bid": "1.95"
}
],
"gamma_profile": {
"ticker": "SRPT",
"spot": 19.84,
"date": "2026-08-19",
"flip_point": 18.54,
"net_gex": 166239.1,
"call_walls": [
{
"strike": 20.0,
"gex": 110020.99
},
{
"strike": 19.0,
"gex": 49002.84
},
{
"strike": 25.0,
"gex": 16395.51
}
],
"put_walls": [
{
"strike": 20.0,
"gex": -31884.41
},
{
"strike": 17.5,
"gex": -21397.72
},
{
"strike": 15.0,
"gex": -19672.51
}
],
"by_strike": [
{
"strike": 14.0,
"call_gex": 0.0,
"put_gex": -5.47,
"net_gex": -5.46
},
{
"strike": 14.5,
"call_gex": 0.0,
"put_gex": -19.77,
"net_gex": -19.77
},
{
"strike": 15.0,
"call_gex": 10388.33,
"put_gex": -19672.51,
"net_gex": -9284.18
},
{
"strike": 15.5,
"call_gex": 0.0,
"put_gex": -14.37,
"net_gex": -14.37
},
{
"strike": 16.0,
"call_gex": 1075.46,
"put_gex": -691.03,
"net_gex": 384.43
},
{
"strike": 16.5,
"call_gex": 2.1,
"put_gex": -997.36,
"net_gex": -995.26
},
{
"strike": 17.0,
"call_gex": 2366.98,
"put_gex": -1634.35,
"net_gex": 732.62
},
{
"strike": 17.5,
"call_gex": 12663.62,
"put_gex": -21397.72,
"net_gex": -8734.1
},
{
"strike": 18.0,
"call_gex": 13150.29,
"put_gex": -830.04,
"net_gex": 12320.25
},
{
"strike": 18.5,
"call_gex": 14951.08,
"put_gex": -103.5,
"net_gex": 14847.58
},
{
"strike": 19.0,
"call_gex": 49002.84,
"put_gex": -22.33,
"net_gex": 48980.51
},
{
"strike": 19.5,
"call_gex": 9815.49,
"put_gex": 0.0,
"net_gex": 9815.49
},
{
"strike": 20.0,
"call_gex": 110020.99,
"put_gex": -31884.41,
"net_gex": 78136.59
},
{
"strike": 20.5,
"call_gex": 118.21,
"put_gex": -14.95,
"net_gex": 103.26
},
{
"strike": 21.0,
"call_gex": 406.79,
"put_gex": -13.3,
"net_gex": 393.49
},
{
"strike": 21.5,
"call_gex": 85.35,
"put_gex": -56.87,
"net_gex": 28.48
},
{
"strike": 22.0,
"call_gex": 330.8,
"put_gex": -117.15,
"net_gex": 213.65
},
{
"strike": 22.5,
"call_gex": 5572.17,
"put_gex": -3838.89,
"net_gex": 1733.28
},
{
"strike": 23.0,
"call_gex": 237.81,
"put_gex": -325.34,
"net_gex": -87.53
},
{
"strike": 24.0,
"call_gex": 152.2,
"put_gex": -1.81,
"net_gex": 150.39
},
{
"strike": 25.0,
"call_gex": 16395.51,
"put_gex": -2974.95,
"net_gex": 13420.56
},
{
"strike": 26.0,
"call_gex": 19.0,
"put_gex": -21.54,
"net_gex": -2.54
},
{
"strike": 27.0,
"call_gex": 5.05,
"put_gex": -0.89,
"net_gex": 4.15
},
{
"strike": 27.5,
"call_gex": 1931.9,
"put_gex": -4.1,
"net_gex": 1927.79
},
{
"strike": 28.0,
"call_gex": 3.5,
"put_gex": 0.0,
"net_gex": 3.5
}
]
},
"oi_changes": {
"net_call_oi_change": -90,
"net_put_oi_change": 0,
"top": [
{
"strike": "17.5",
"oi_change": -96,
"type": "call"
},
{
"strike": "20",
"oi_change": 6,
"type": "call"
},
{
"strike": "5",
"oi_change": 0,
"type": "put"
},
{
"strike": "7.5",
"oi_change": 0,
"type": "put"
},
{
"strike": "15",
"oi_change": 0,
"type": "put"
}
]
}
}
Data:
{
"vix": 14.25,
"sp500": 7785.76,
"fed_funds": 3.63,
"yield_curve_10y2y": 0.51,
"hy_spread": 2.71,
"treasury": {
"date": "2026-08-17",
"month1": 3.79,
"month2": 3.82,
"month3": 3.87,
"month6": 3.95,
"year1": 4,
"year2": 4.19,
"year3": 4.25,
"year5": 4.38,
"year7": 4.54,
"year10": 4.72,
"year20": 5.3,
"year30": 5.31
},
"events": [
{
"title": "FOMC Meeting Minutes",
"currency": "USD",
"date": "2026-08-19",
"time_utc": "18:00",
"impact": "High",
"forecast": null,
"previous": null,
"actual": null,
"minutes_until": 206
}
]
}
Data:
{
"days": 40,
"patterns": [
{
"name": "VWAP Touch",
"count": 40,
"pct": 100
},
{
"name": "9 EMA Touch",
"count": 40,
"pct": 100
},
{
"name": "21 EMA Touch",
"count": 40,
"pct": 100
},
{
"name": "ORB Breakout",
"count": 38,
"pct": 95
},
{
"name": "PDH/PDL Touch",
"count": 37,
"pct": 92
},
{
"name": "Woodie Pivot Touch",
"count": 37,
"pct": 92
},
{
"name": "Gap Fill",
"count": 31,
"pct": 78
},
{
"name": "Open Retracement",
"count": 27,
"pct": 68
},
{
"name": "Darvas Box",
"count": 10,
"pct": 25
},
{
"name": "High Vol Open",
"count": 9,
"pct": 22
},
{
"name": "Power Hour",
"count": 3,
"pct": 8
}
]
}